Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.41 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12895938 | 0.96 | MAPT (0.52) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL10556725 | 0.87 | TDP1 (0.58) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL10554618 | 0.87 | TDP1 (0.58) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL18211042 | 0.85 | TDP1 (0.56) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL18211041 | 0.85 | TDP1 (0.56) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL25473109 | 0.82 | TDP1 (0.53) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL12246385 | 0.82 | TDP1 (0.53) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL13744749 | 0.82 | TDP1 (0.53) | MAPTMEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL8777494 | 0.79 | TDP1 (0.68) | TDP1L3MBTL1ALDH1A1GAAPOLB | |
| SCHEMBL17798767 | 0.79 | TDP1 (0.50) | MAPTMEN1KMT2ATDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | claimed |
| EP-2104676-A2 | METHODS FOR PREPARING ARENE-BIS(DICARBOXIMIDE)-BASED SEMICONDUCTING MATERIALS AND RELATED INTERMEDIATES FOR PREPARING SAME | Polyera Corporation (US) | 2009-09-30 | — | — | EP | claimed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | claimed |
| WO-2008085942-A2 | METHODS FOR PREPARING ARENE-BIS(DICARBOXIMIDE)-BASED SEMICONDUCTING MATERIALS AND RELATED INTERMEDIATES FOR PREPARING SAME | POLYERA CORPORATION (US) | 2008-07-17 | — | — | WO | claimed |
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | disclosed |
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | disclosed |
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | disclosed |
| US-7892454-B2 | Such as 2,3:6,7-anthracenedicarboximide derivatives; air stability, solution processability; n type; organic thin film transistors, light emitting diodes and photovoltaic devices; long lasting | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080185555-A1 | Acene-based organic semiconductor materials and methods of preparing and using the same | USINVEST LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | disclosed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | disclosed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | disclosed |
| WO-2008085942-A2 | METHODS FOR PREPARING ARENE-BIS(DICARBOXIMIDE)-BASED SEMICONDUCTING MATERIALS AND RELATED INTERMEDIATES FOR PREPARING SAME | POLYERA CORPORATION (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008063583-A1 | ACENE-BASED ORGANIC SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USING THE SAME | POLYERA CORPORATION (US) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | RECQL, CCNE2, CCNE1 | MAPT 3063/4885MEN1 658/4885KMT2A 1140/4885 |
| US-20080185555-A1 | Acene-based organic semiconductor materials and methods of preparing and using the same | ACE, ACE2, AGT | MAPT 2518/4885MEN1 1124/4885KMT2A 1683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.